Background Depression is common among patients with axial spondyloarthritis (axSpA), but
reports of its prevalence are highly variable. We performed a systematic review to (i) …

Axial spondyloarthritis (AxSpA) is an inflammatory spondyloarthritis (SpA) that has
significant impact on a patient's life. Symptoms, including fatigue, sleep problems …

Purpose The purpose of this paper is to focus on understanding how social influence and
personality of individuals differentiate between users' social network fatigue and …

Ankylosing spondylitis (AS) is a complex systemic rheumatological disease which often
causes severe disability and impaired quality of life (QoL). We searched the …

Objective Secukinumab improved the signs and symptoms of ankylosing spondylitis (AS)
over 52 weeks in the phase III MEASURE 2 study. Here, we report longer‐term (104 weeks) …

Introduction Literature data suggest that sleep disturbances are prevalent among patients
with ankylosing spondylitis (AS) and have a close correlation with pain. Other studies …

Objective To evaluate the effect of secukinumab (interleukin‐17A inhibitor) on patient‐
reported outcomes in patients with active ankylosing spondylitis (AS). Methods In this phase …

Background Secukinumab, a fully human monoclonal antibody that directly inhibits
interleukin 17A, has shown significant and sustained improvement in the signs and …

Objective. In this study, we aimed to address the prevalence of fatigue, its associated factors,
and the effect of tumor necrosis factor inhibitors (TNFi) on this subgroup of patients in a large …

Abstract Background Ankylosing Spondylitis (AS) patients face several challenges due to
the nature of the disease and its physical and psychological complications. Sleep disorders …